Name: Sustainable care for children with cancer: a Lancet Oncology Commission
Start: 2020-11-18T13:00:00Z
End: 2020-11-18T13:01:55.000Z
Location: BrightTALK
Rating: 4.6

As a researcher, you want to learn techniques and strategies to set yourself up for publishing success. On our premium content channel, you can find useful resources to learn the best practices on preparing manuscripts for publication and discovering the best journal for your research. Join esteemed editors from premium journals like Cell Press, The Lancet and Societies like ACC, AWHONN, AATS and many others to learn tips on publishing in top journals.

Chemical ecology integrates advances in chemistry and biology to better understand chemically-mediated biological interactions, how these interactions affect organismal behaviors and evolution, the relevance of these interactions to ecosystems, and the underlying mechanisms of chemical signaling within and between organisms. In this Cell Press webinar, Shinichi Sunagawa (ETH Zurich), Christelle A. M. Robert (Universitat Bern), and Emily R. Burdfield-Steel (Universiteit van Amsterdam) will discuss chemical interactions between ocean and gastrointestinal microbes and their hosts, plants and soil invertebrates, and mating insects. A discussion will follow hosted by editors from Cell, iScience, Trends in Ecology and Evolution, and Cell Genomics specifically on the interdisciplinary crosstalk in this area.

Speakers:

Prof. Shinichi Sunagawa is in the Department of Biology at ETH Zürich where he has led the Sunagawa Lab of Microbiome Research since 2016. Prof. Sunagawa is interested in studying ecological and evolutionary factors that determine the structure, function and diversity of microbial communities, currently focusing on the ocean ecosystem and the gastrointestinal tract of animals and humans. 

Prof. Dr. Christelle A. M. Robert is Head of the Chemical Ecology Group in the Institute of Plant Sciences at University of Bern in Bern, Switzerland and she is a chemical ecologist working on plant-herbivore interactions below ground, their ecological relevance, and underlying mechanisms.

Dr Emily R. Burdfield-Steel is an Assistant Professor of Chemical Ecology in the Institute for Biodiversity and Ecosystem Dynamics (IBED) at the University of Amsterdam (UvA). Dr Burdfield-Steel's areas of study are the evolution of mating communication systems in response to reproductive interference and the role of chemical and visual signals in aposematic insect populations.

Understanding the chemical mediators of ecological interactions

International collaborations have long been an important element of genomic science. In recent years, however, a number of factors have driven remarkable growth in global collaboration: the growth of information technologies, an increased emphasis on large cohorts with diverse representation, and rare disease therapeutics advances, just to name a few. With this shifting scope, work to address ethical challenges created by international collaboration has become an increasingly important part of the genomic science landscape. Nowhere are these challenges more pressing than in the work of scientific journals. While regulators, funders, and individual institutions tend to focus on issues specific to their setting, scientific journals encounter these issues on a truly broad, comprehensive, and international scale, serving as the final common pathway for a remarkable array of scientific techniques and strategies, varieties of collaborations, and regulatory jurisdictions. Scientific journals thus serve as critical stakeholders in ensuring that ethical considerations have been addressed prior to dissemination. In this session, Dr. Kyle Brothers, chair of the Ethics Advisory Committee for Genetics in Medicine, will examine the ethical issues raised by international collaboration in genomic science, with a focus on helping journals adopt practices that ensure published science has been conducted in a manner that protects the rights and welfare of research participants.

Ethical Issues in the Dissemination of Genomic Science: Perspectives from GIM

Targeted agents, immune and cellular therapies and other novel agents have led to dramatic shifts in the treatment of many hematologic malignancies (HM).  These therapies bear toxicities that are unique, chronic or delayed relative to conventional chemotherapies. Many are administered for months to years, impacting treatment tolerability over time.  In this context, a global, multi-disciplinary Lancet Haematology Adverse Events (AE) Commission comprised of patient advocates, clinical investigators, regulators and other stakeholders was assembled to examine and propose solutions to modernize AE assessment.  In this webinar, Commission leads will update key priorities in improving AE evaluation with a focus on patients with HM not only living longer but living better.
Presenters:
Gita Thanarajasingam, Mayo Clinic, USA
Amylou Dueck, Mayo Clinic, USA
Lori Minasian, the US National Cancer Institute (NCI), USA
Surbhi Sidana, Stanford University, USA
Karin Ekstrom-Smedby, Karolinska Institutet, Sweden
Nicole Gormley, U.S. Food and Drug Administration (FDA), USA
Tarec Christoffer El-Galaly, Aalborg University Hospital, Denmark

Modernising haematological malignancy adverse event assessment and reporting

With the continued rise of interdisciplinary approaches bridging life and physical sciences, researchers are using every toolkit available to tackle the most pressing health problems. Med and Matter recognize that not only are emerging in medical technologies being developed on innovative and advanced materials platforms, but biological materials themselves can be designed similarly to synthetic materials systems. Simply put, the underlying materials used for medicine matter. Recently, RNA has entered the forefront of emerging therapeutics, requiring new fundamental approaches to predictive modeling and design of RNA, RNA delivery platforms, and clinical use. Join us to hear about the latest advances from our excellent panel!

Speakers:

Giovanni Traverso is an assistant professor in the department of mechanical engineering at the Massachusetts Institute of Technology (MIT) and also a gastroenterologist with Brigham and Women’s Hospital (BWH), Harvard Medical School. His current research program is focused on developing the next generation of drug delivery systems to enable safe and efficient delivery of therapeutics, working on a biomedical device to support new modes of drug administration, and sensing a broad array of physiologic and pathophysiologic signals. 

Laura Sepp-Lorenzino, PhD joined Intellia Therapeutics in 2019 as chief scientific officer and is responsible for research and early development. Intellia’s leading CRISPR platform supports a full-spectrum therapeutic strategy. Laura previously held leadership positions at Vertex, Alnylam, and Merck.

Dr. Ryan Flynn is an assistant professor at Boston Children’s Hospital in the Stem Cell Program and the department of Stem Cell and Regenerative Biology at Harvard University, where his lab is investigating the chemical nature and biological role of RNA glycosylation. Dr. Flynn has won multiple awards including the Burroughs Wellcome Fund, the Sontag Foundation, and the Rita Allen Foundation Scholars Award.

Med platforms Matter: Emerging strategies for RNA therapeutics

The development of clean energy conversion technologies plays a fundamental role in addressing the global environment and climate change challenges caused by high-carbon emissions. To celebrate the 1st anniversary of Chem Catalysis, the award-winning Cell Press title Chem presents a joint webinar to discuss the progress of sustainable catalysis. Prof. Shizhang Qiao (University of Adelaide), Prof. Motomu Kanai (The University of Tokyo) Prof. Lizhu Wu (Technical Institute of Physics and Chemistry, CAS), and Prof. Shuhong Yu (University of Science and Technology of China) will introduce complementary aspects of catalysis research for clean energy applications, covering the topics of emerging photo-/electrocatalysis, artificial photosynthesis, small-molecule activation and green synthesis.

Catalysis for Clean Energy

Good city planning produces co-benefits for individual and planetary health and wellbeing. In 2016, the Lancet Series on urban design, transport, and health drew attention to the importance of integrated upstream city planning policies as a pathway to creating healthy and sustainable cities and proposed a set of city planning indicators that could be used to benchmark and monitor progress. 

In this follow-up series, published in The Lancet Global Health, the authors show how the indicators can guide decisions about what must change to create healthy and sustainable cities and how research can be used to guide urban policy to achieve urban and population health. They provide tools that other cities can use to replicate the indicators and explore “where to next” to create healthy and sustainable cities, particularly in light of the COVID-19 pandemic and climate change.  

In this Webinar, the lead Series authors will present their work and will be joined by an external panel of stakeholders to discuss what the recommendations mean for them. There will be an opportunity at the end to ask questions.

Presenters:
Zoë Mullan - The Lancet Global Health, UK
Billie Giles-Corti - RMIT University, Australia 
Melanie Lowe - University of Melbourne, Australia
Ester Cerin - Australian Catholic University, Australia
Geoff Boeing - University of Southern California, USA
 Deborah Salvo - Washington University, USA
Carl Higgs - RMIT University, Australia
Felix John -  Cycling Mayor, India
Rachel Huxley - C40 Cities, UK 
Thiago Hérick de Sá - World Health Organisation, Switzerland

Urban design, transport, and health

Good city planning produces co-benefits for individual and planetary health and wellbeing. In 2016, the Lancet Series on urban design, transport, and health drew attention to the importance of integrated upstream city planning policies as a pathway to creating healthy and sustainable cities and proposed a set of city planning indicators that could be used to benchmark and monitor progress. 

In this follow-up series, published in The Lancet Global Health, the authors show how the indicators can guide decisions about what must change to create healthy and sustainable cities and how research can be used to guide urban policy to achieve urban and population health. They provide tools that other cities can use to replicate the indicators and explore “where to next” to create healthy and sustainable cities, particularly in light of the COVID-19 pandemic and climate change.  

In this Webinar, the lead Series authors will present their work and will be joined by an external panel of stakeholders to discuss what the recommendations mean for them. There will be an opportunity at the end to ask questions.

Presenters:
Zoë Mullan - The Lancet Global Health, UK
Billie Giles-Corti - RMIT University, Australia
Melanie Lowe - University of Melbourne, Australia
Ester Cerin - Australian Catholic University, Australia
Geoff Boeing - University of Southern California, USA
 Deborah Salvo - Washington University, USA
Carl Higgs - RMIT University, Australia 
 Felix John -  Cycling Mayor, India
Joanna Frank - Centre for  Active Design, USA
Fiona Bull - World Health Organisation, Switzerland

We invite you to join the free webinar, in Chinese language, with Dr. Yanfei Zhu, Scientific Editor of Chem Catalysis journal (Cell Press), to learn best practices on submitting your work for publication. The presentation will be followed by a Q&A with the editor.

In this webinar, you can expect to learn about:
• Publishing opportunities at Cell Press, an all-sciences publisher
• Why is it important to read high quality interdisciplinary content?
• China research landscape
• How to prepare your manuscript for submission
• The process of reviewing papers and the editorial decision making at Cell Press

Don’t forget to extend this invitation to your colleagues who might find this of interest! 

About the presenter:
Dr. Yanfei Zhu obtained her master's degree in 2017 from the University of Copenhagen (Demark) and PhD degree from the National Center for Nanoscience and Technology (NCNST, CAS, China). After that, she worked as a postdoctoral fellow at NCNST. She joined the Chem Catalysis team as a scientific editor in 2021 and is currently based in the Shanghai office. Yanfei specializes in heterogeneous catalysis, material sciences, and energy-related applications.

Essential Tips for Publishing in High Impact Journals

Join our interactive webinar session with Kalyanam Shivkumar, MD, PhD, FACC, editor-in-chief of JACC: Clinical Electrophysiology to learn strategies on how to for developing a translational research career, which can bridge basic sciences to the clinical world. You can expect to learn about the key components that are required for developing a successful research career, which includes; initial training, developing life-long learning skills, identifying important scientific questions and finally, team building to reach your goals. This webinar will address the following specific areas along with illustrative examples:
• Picking a problem/evaluating an idea
• Gathering preliminary data
• Grant submission
• Analysis and interpretation of data
• Overview of the publication process
• Universal challenges faced by translational researchers and how to tackle them - the 4 P’s and 8 C’s
Sign up for this engaging session with Dr. Shivkumar today and get an opportunity to find answers to your pressing questions during the Q&A session of the webinar.

About JACC Journals
Encompassing the Journal of the American College of Cardiology (JACC) and nine specialty journals, the family of JACC Journals is one of the most widely read, most impactful cardiovascular journal programs in the world. Aligned with the ACC’s mission to transform cardiovascular care and improve heart health, the Journals continuously striving to provide the best resources for cardiovascular investigators, clinicians and specialists at every professional stage. JACC: Basic to Translational Science, the JACC: Clinical Electrophysiology Innovations in Basic/Translational EP manuscript category, and the entire family of JACC Journals serve as publication avenues for translational science.

Best Practices in Translational Research

Developing clean energy technologies and environmentally sustainable processes is now widely accepted to be vital to address the global issues of the 21st century. Bioenergy and bioengineering are important emerging interdisciplinary research areas that are poised to make major contributions towards solving these problems. This sphere of research also represents a significant cross-over space for two of Cell Press’ flagship journals in the biological and physical sciences, Cell and Joule.

In this webinar, leading experts Jean-Michael Ané, Patrick Shih, Sarah Glaven, and Jenny Zhang, discuss 4 key topic areas: artificial photosynthesis, nitrogen fixation, bioengineering of methylotrophs and electromicrobiology. Following the talks there will be a panel discussion with our speakers, with opportunity for audience questions and continued discussion. The goal of this webinar is to bring together the biology, energy, and physical science communities to discuss progress and challenges in bioenergy/bioengineering research as well as the potential solutions that will enable their implementation.

Bioengineering for renewable energy and a sustainable future

Learn about the brief history of Genetics in Medicine and its path to being a leading publication for research in medical genetics and genomics. Focusing on the journal’s mission, aims, and scope, the editor-in-chief Robert D. Steiner will provide insight to help you determine if the journal is the right fit for your research as well as what the editors are looking for when selecting manuscripts for publication in Genetics in Medicine. The webinar will also address new initiatives intended to broaden the scope of the journal such as therapeutics, biomedical informatics, economics and health services.  
Finally, Dr. Steiner will speak to how Genetics in Medicine promotes your work after publication on the journal’s social media channels and how to access social media metrics at the article level to measure the impact and engagement of your article. 

Sign up for this engaging webinar and get a chance to find answers to your pressing questions during the interactive Q&A session of the webinar.

About Robert D. Steiner, Editor-in Chief, Genetics in Medicine
Robert D. Steiner, MD, FAAP, FACMG served as a section editor for the journal since 2006 and deputy editor since 2011.  He is Professor (Clinical) of Pediatrics at the University of Wisconsin (UW) School of Medicine and Public Health, Chief Medical Officer for PreventionGenetics, and Wisconsin Department of Health Service newborn screening program medical consultant. After obtaining his MD from UW, he completed a residency in pediatrics at The University of Cincinnati/Cincinnati Children’s Hospital and Medical Center.  Dr. Steiner trained in medical genetics at The University of Washington/Seattle Children’s Hospital and Regional Medical Center. He is board certified in Pediatrics, Clinical Genetics, and Clinical Biochemical Genetics.

Publishing in GIM:  The old and the new

Finding the right journal to publish your research and structuring your research to publish in premium journals can be a challenge. Learn techniques and strategies to publish in premium journals like the Journal of Thoracic and Cardiovascular Surgery (JTCVS) with Richard D. Weisel, Editor, JTCVS, Y. Joseph Woo, Associate Editor, MD, Adult and Thomas A. D’Amico, MD, Thoracic.

You can expect to learn about:
-Manuscript preparation tips
-Features of successful manuscripts
-Editorial process
-How to publish in JTCVS
-New Initiatives at the Journal

Sign up for the free webinar workshop today and extend the invitation to your colleagues who may find this helpful.

About Journal of Thoracic and Cardiovascular Surgery:
The Journal of Thoracic and Cardiovascular Surgery presents original, peer-reviewed articles on diseases of the heart, great vessels, lungs and thorax with emphasis on surgical interventions. An official publication of The American Association for Thoracic Surgery and The Western Thoracic Surgical Association, the Journal focuses on techniques and developments in acquired cardiac surgery, congenital cardiac repair, thoracic procedures, heart and lung transplantation, mechanical circulatory support and other procedures.

How to Publish with The Journal of Thoracic and Cardiovascular Surgery

With the continued rise of interdisciplinary approaches bridging life and physical sciences, researchers are using every toolkit available to tackle the most pressing health problems. Med and Matter recognize that multiple driving technologies emerging in medicine are being developed on innovative and advanced materials platforms; these technologies exploit the behavior of novel materials and phenomena, including biocompatible chemistries and mechanics, adaptive structures, transport properties, photodynamics, and more. Simply put, the underlying platforms used for medicine matter. Here, we focus on materials-based solutions for potential cancer treatment, diagnostics, and the next generation of personalized medicine. 

About the speakers

Dr. Ali Khademhosseini is the CEO of the Terasaki Institute for Biomedical Innovation. Formerly, he was the Levi Knight Professor of Bioengineering, Chemical Engineering, and Radiology at the University of California-Los Angeles (UCLA), and also a Professor at Harvard Medical School and the Wyss Institute. Khademhosseini is best known for developing hydrogels for tissue engineering and bioprinting.

Dr. Natalie Artzi holds research appointments at Harvard Medical School, MIT, and the Broad Institute of MIT and Harvard. Dr. Artzi is the recipient of multiple grants and awards, including the One Brave Idea; Stepping Strong Innovator, and Breakthrough Awards; Controlled Release Society Young Investigator Award; Mid-Career Award from the Society for Biomaterials; and the Bright Futures Prize.

Dr. Wei Tao is an assistant professor at the Harvard Medical School. Dr. Tao has received multiple awards and grants, including the U.S. METAvivor Early Career Investigator Award; Harvard Anesthesia Department Basic Scientist Grant; Khoury Innovation Award; Center for Nanomedicine Research Fund; Stepping Strong Breakthrough Innovator Award (Co-PI); and the American Heart Association (AHA) Collaborative Sciences Award (Co-PI).

Med platforms Matter: Materials science for cancer diagnostics and treatment

Learn techniques and strategies for publishing in transformative ground-breaking journals with Dr. Lewis Collins, Editor-in-Chief of One Earth (a Cell Press journal). Dr. Collins will share tips on developing your papers for ground-breaking publications, elaborate on his experience of working with researchers and authors throughout the research publishing cycle and the opportunity to broadly disseminate findings. Dr. Collins will also share more details about the growth of Cell Press journals in the physical and environmental sciences field, including the launch of many new titles such as Chem, Matter, Joule, and One Earth. He’ll outline Cell Press’ approach to high-demand, multi-disciplinary content, and expanding OA publishing strategies at Cell Press. Join this engaging webinar to find the answers to your pressing questions in the Q&A session during the webinar. Don’t forget to extend this invite to your colleagues who might find this of interest.

About Lewis Collins:
Inspired by David Attenborough documentaries as a child, Lewis has been amazed by the natural world from an early age. While undergraduate and master’s degrees in Earth science (Cardiff University), and Climate Change (University of East Anglia) nurtured this interest, it was doctoral (British Antarctic Survey) and post-doctoral (Université Pierre et Marie Curie) research on Antarctica that centered his focus on environmental change. Prior to launching One Earth, Lewis spent over 5 years with Nature Communications, where he led the Earth editorial team and curated, commissioned, handled (and occasionally rejected…) research across the full spectrum of Earth and environmental science. Lewis is particularly interested in grand challenges associated with land-use and the competing demands for this increasingly scarce resource.

Techniques for Publishing in Transformative Ground-Breaking Journals

Join this interactive webinar session with Bonnie Ky, MD, MSCE, FACC, Editor-in-Chief of JACC: CardioOncology to learn strategies on how to develop a clinical research career, with examples of how to successfully ask and answer research questions in cardio-oncology. You can expect to learn about the following:
- Important components of building a successful research career from scientific questions to team building
- Grant submission
- Overview of the publication process
- Key challenges faced by every clinical researcher and how to tackle them to build a successful career

Sign up for this engaging session with Dr. Bonnie Ky today and get an opportunity to find answers to your pressing questions during the Q&A session of the webinar.

About Bonnie Ky, MD, MSCE, FACC:
Dr. Bonnie Ky is the Founders Associate Professor of Medicine and Epidemiology and tenured physician-scientist at the University of Pennsylvania and serves as the Director for the Penn Center for Quantitative Echocardiography and is the founding Director of the Penn Cardio-Oncology Translational Center of Excellence. She leads a highly active NIH-funded translational research program in cardio-oncology and is the PI of multiple investigator-initiated cohort studies and clinical trials focused on the study of the cardiotoxic effects of doxorubicin, trastuzumab, sunitinib, and radiation therapy in breast, renal cell, and lung cancers, and lymphoma patients.

How to Develop a Multi-disciplinary Clinical Research Career

Learn techniques and strategies for getting published in JACC journals with Dr. David J. Moliterno, MD, FACC, Editor-in-Chief, JACC: Cardiovascular Interventions. Dr. Moliterno will present information on publishing in JACC Journals. Dr. Moliterno will share his expertise in working with researchers and authors throughout the research publishing cycle, how to develop papers for premium publications, and the opportunity to broadly disseminate findings. One of eight JACC Journals published by the American College of Cardiology (ACC), JACC: Cardiovascular Interventions disseminated top science in interventional cardiovascular medicine, including coronary, structural, peripheral and cerebrovascular diseases. You won’t want to miss this engaging webinar and how it can benefit your research process and impact. Learn about submitting to JACC Journals and subscribe to eTable of Content emails.

About Dr. David J. Moliterno
Dr. Moliterno is the Editor-in-Chief of JACC: Cardiovascular Interventions. He is the Jack M. Gill Chair and Professor of the Department of Internal Medicine at the University of Kentucky. He is also a member of the interventional cardiology faculty at the Gill Heart and Vascular Institute in Lexington, Kentucky. He has been involved with numerous investigational studies in cardiovascular medicine over the last two decades, with his primary research interest being in acute coronary syndromes. Prior to assuming position as Editor-in-Chief, Dr. Moliterno served as an associate editor for the journal. An active member of the ACC, Dr. Moliterno has been a member of the Board of Governors, Strategic Education Committee, and the Interventional Section Leadership Council.

Must Know Tips for Publishing In JACC Journals

Learn all about innovation, growth in the multi-disciplinary content and the expanding open access publishing strategy at Cell Press with Dr. Deborah Sweet, Senior Vice President of Publishing at Cell Press. 

You can expect to learn more about the community outreach programs at Cell Press like webinars, symposia, Cell Mentor, Sneak Peek, STAR Methods, STAR Protocols and much more which can help your researchers as well as institutes to grow faster and deliver a higher impact in the world. 

We promise to make the webinar engaging and to answer all your questions around Cell Press. At Cell Press, everything we do aims to drive research forward — whether it's working with authors, enhancing the peer review process, or developing innovations in publishing. We put science first, science that people talk about. 

Join Dr. Sweet in this engaging webinar and make sure to bring along your colleague and friends who may benefit from these helpful resources.

Innovation at Cell Press: Make the most of free Cell Press resources

Join Luke Batchelor, Ph.D., Editor-in-Chief, Cell Reports Physical Sciences for an engaging webinar to learn about techniques and strategies for authoring in high impact journals. Luke will present his experience working with researchers and authors throughout the research publishing cycle, how to develop papers for premium publications, and the opportunity to broadly disseminate findings. Luke will talk to you about growth of Cell Press journals in the physical sciences field, which includes launch of many new titles such as Chem, Joule, Matter, and One Earth. He’ll also outline Cell Press’ approach to high-demand, multi-disciplinary content, and expanding OA publishing strategies at Cell Press. You won’t want to miss this informative webinar and how it can benefit your research process and impact. Please extend this invite to colleagues who may also find it of interest.

More about Dr. Luke Batchelor:
A chemist by training, Luke obtained his undergraduate degree from the University of Bristol and his PhD from the University of Manchester, which was then followed by postdoctoral work at Manchester and Université Paris Sud XI. In 2012, Luke moved to Nature Communications, covering a range of topics in chemistry and materials science; and in 2017, he led the launch of Communications Chemistry. Luke joined Cell Press in 2019 and is based in the London office

Navigating the Publishing Process for High Impact Journals

Cancer kills more than 100,000 children each year, and yet 80% of pediatric cancers are curable with currently available interventions. Notably, the majority of these deaths occur in low‐income and middle-income countries. Yet no reliable data are available in low-income and middle-income countries on the burden of childhood cancer; on the cost of effective interventions; on current health coverage levels; or on the cost, feasibility, or health and economic benefits of scaling-up effective coverage.

In March, 2020, The Lancet Oncology published a Commission on Sustainable care for children with cancer, which provided a new analysis of the global childhood cancer burden and developed an economic investment case and evidence-based medical framework for implementing, integrating, and scaling up care pathways for childhood cancer.

Join Dr. Ali Landman, Deputy Editor of The Lancet Oncology, and Commission authors, as they discuss the aims, findings, and recommendations from the Commission.

Sustainable care for children with cancer: a Lancet Oncology Commission

Cancer

paediatric cancer

low-income countries

middle-income countries

childhood cancer

health coverage

Oncology

The Lancet

The medical research community on BrightTALK brings together medical and research professionals. Find relevant webinars on medical research, laboratory science, continuing medical education and more presented by recognized medical researchers. Join the conversation by participating in live webinars and round table discussions on the latest in medical devices, medical research practices and trends in the healthcare industry.

Medical Research

Thousands of healthcare IT professionals compose the health IT community on BrightTALK. Learn alongside them with relevant webinars on healthcare IT compliance, big data in healthcare and IT solutions for healthcare organizations. Join the conversation by asking questions and engaging with other participants during live webinars and organized discussions.

Health IT

Get powerful life science insights from influential experts. Connect with thought leaders and colleagues to get the most up-to-date knowledge on strategies and initiatives to accelerate the transformation of U.S. and global health care from a volume- to value-based marketplace.

Life Sciences

Healthcare

Join the BrightTALK forensic science community for access to online forensics training from respected professionals in the field. Study forensic science online to learn necessary skills for trace evidence in forensics, liquid and gas chromatography and sample preparation. You can also attend live webinars to interact with forensic scientists and have your questions answered.

Forensic Science

The research and development community on BrightTALK brings together leading professionals in healthcare, technology and manufacturing to present on current topics in their fields. From big data in healthcare to online forensics training and medical research practices, the community is an exceptional resource for those looking to expand their knowledge. Be part of the conversation by joining the community and participating in interactive live webinars.

Sustainable care for children with cancer: a Lancet Oncology Commission

Presented by

About this talk

More from this channel